Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) May 31, 2025
Volume 46 Issue 2
Mar.  2015
Turn off MathJax
Article Contents
CEN Xiao-min, LIANG Yan, XIE Qi-bing. et al. Comparison of Four Assessment Criteria for Disease Activity of Rheumatoid Arthritis[J]. Journal of Sichuan University (Medical Sciences), 2015, 46(2): 280-284.
Citation: CEN Xiao-min, LIANG Yan, XIE Qi-bing. et al. Comparison of Four Assessment Criteria for Disease Activity of Rheumatoid Arthritis[J]. Journal of Sichuan University (Medical Sciences), 2015, 46(2): 280-284.

Comparison of Four Assessment Criteria for Disease Activity of Rheumatoid Arthritis

More Information
  • Published Date: March 19, 2015
  • Objective To compare of the efficacy of four assessment criteria for evaluating disease activity in rheumatoid arthritis. Methods Clinical data were collected from 172 patients ofrheumatoid arthritis.Disease activity was evaluatedby four assessment criteria, which are disease activity score 28-C-reactive protein (DAS28-CRP), disease activity score 28-erythrocyte sedimentation rate (DAS28-ESR), simplified disease activity index (SDAI) and clinical disease activity index (CDAI).The patients were divided into four groups which were remission, low, middle and high disease activity.The correlations and consistencies among four methods were compared. Results Disease activities evaluated by four methods in 172 RA patients were significantly positive correlated (\P<0.01). It was significantly consistent between SDAI and CDAI,also between DAS28-ESR and DAS28-CRP,the \Kappa values were 0.949 and 0.862 respectively. The differences of the four methods in remission and high disease activity groups were no statistical significance.The proportion of the patients in low disease activity and middle disease activity groups evaluated by DAS28-ESR and DAS28-CRP were statistical different from that evaluated by CDAI and SDAI (\P<0.05).Conclusion Strong correlation was observed between the four methods.CDAI could be used to evaluate whether RA is remission or activity. For disease activity assessment,DSA28-ESR and DAS28-CRP seems superior to CDAI and SDAI.
  • Cited by

    Periodical cited type(27)

    1. 武冬梅. 艾拉莫德联合甲氨蝶呤治疗类风湿关节炎的临床效果和安全性评估. 现代医学与健康研究电子杂志. 2025(05): 98-100 .
    2. 陈家涟,朱田田,杨东宇,刘晓玥,赵中亭. 类风湿关节炎活动度评定方法的应用现状及信效度研究概述. 实用中医内科杂志. 2024(02): 38-42 .
    3. 罗丽平,申悦,苗婕妤,赵旭,马伶俐,徐胜前. 类风湿性关节炎合并原发性高血压的危险因素分析. 安徽医学. 2024(07): 805-810 .
    4. 黄小艳,何江,彭坤世. 电针联合硒温泉治疗风寒湿痹型类风湿关节炎的效果及对炎症因子的影响. 中国医学创新. 2024(36): 138-142 .
    5. 王玮玮,陈惠霞. 甲氨蝶呤联合阿达木单抗或来氟米特治疗类风湿关节炎的临床效果及对炎症因子的影响. 中国现代医药杂志. 2023(03): 66-69 .
    6. 张杏芬,张俊峰,陈明伟. 祛湿止痛丸对类风湿关节炎患者的临床疗效. 中成药. 2023(12): 3950-3953 .
    7. 邓汝将,肖运通,康茜,肖叙平,钟桂平. RF-Ig G抗CCP抗体水平联合检测在风湿性关节炎诊断和疾病活动度评估中的应用. 基层医学论坛. 2022(08): 75-77 .
    8. 胡洋扬,李咏梅,常景建. MRI联合超声成像评价类风湿性腕关节炎患者关节活动度的价值. 广西医科大学学报. 2021(04): 800-805 .
    9. 张妍,黄国治,姚专,宋攀,李庆玲. 类风湿关节炎患者血清SP、GDF-15水平与疾病活动度及亚临床动脉粥样硬化的相关性研究. 国际检验医学杂志. 2021(15): 1811-1815 .
    10. 王振杰,王菁,王晓东,程海华. CCL5、CCL18、CXCL13在类风湿关节炎患者血清和滑液中的表达及临床意义. 实验与检验医学. 2020(01): 133-136 .
    11. 郑裕彬. 糖皮质激素药物辅助常规药物治疗类风湿关节炎的可行性分析. 中外医疗. 2020(07): 110-112 .
    12. 李东. 桂枝芍药知母汤联合来氟米特治疗早期(湿热型)类风湿关节炎临床观察. 光明中医. 2020(19): 3086-3088 .
    13. 古舒梅,曾海峰,杨史珍. 类风湿关节炎患者肌骨超声半定量分级与疾病活动度的关系研究. 深圳中西医结合杂志. 2019(01): 6-7 .
    14. 刘环,杨鹏. 糖皮质激素联合抗风湿类药物治疗类风湿关节炎的临床效果. 临床医学研究与实践. 2019(07): 33-34 .
    15. 张一超,张伟群,杨佳,傅根莲. RA患者RDW水平变化及其与ESR、CRP和RF的关系. 检验医学. 2019(05): 441-442 .
    16. 李姗. 个体化心理护理对类风湿关节炎患者焦虑状态及治疗依从性的影响. 中外医学研究. 2019(20): 84-86 .
    17. 李晓莹,宋亚丽,陈腊梅,王盛华,路麒. 支原体感染与类风湿关节炎发病相关性研究. 中国麻风皮肤病杂志. 2019(07): 419-421 .
    18. 居艳娟,李荣平,郭迪斌,冯雪琴. 白芍总苷对类风湿关节炎肝功能保护、佐治效果研究. 中国现代医生. 2019(30): 34-37 .
    19. 曹芊,曹莹敏. 中药熏蒸联合艾灸治疗活动期类风湿性关节炎临床研究. 新中医. 2019(12): 307-309 .
    20. 罗玲,李慧妍,林海雄. 抗环瓜氨酸肽抗体、类风湿因子、C-反应蛋白、红细胞沉降率在类风湿性关节炎中的临床应用. 中国卫生检验杂志. 2019(23): 2882-2884 .
    21. 张婉. 糖皮质激素联合抗风湿类药治疗类风湿关节炎54例临床研究. 中国药业. 2018(01): 67-69 .
    22. 李勇军,陈婧,陈仁德,张莎莎,李向平,王新,耿一心. 类风湿因子和抗环瓜氨酸肽抗体阴性对类风湿关节炎患者临床分析及血清红细胞沉降率、C反应蛋白水平表达. 中国临床医生杂志. 2018(06): 692-695 .
    23. 吴竹群,王宏智,张斌,马娟妹,苗国芳,张叶. RA疾病活动性评分系统在类风湿关节炎护理管理中的应用. 中国现代医生. 2017(11): 122-124+169 .
    24. 薛媛,张莉芸. 四种评价方法用于评价类风湿关节炎疾病活动度的比较分析. 世界最新医学信息文摘. 2016(24): 17-18 .
    25. 熊俊慧,薛静,丁振华,王小冬,陈坚. 糖皮质激素类药物联合治疗类风湿性关节炎患者的疗效及安全性评价. 中国医院药学杂志. 2016(18): 1582-1585 .
    26. 冷玲丽. 人性化特色护理干预对类风湿性关节炎患者关节活动及生活质量的影响. 中国医学创新. 2016(29): 104-108 .
    27. 尹耕,文富强. 类风湿关节炎的炎症免疫机制及疾病活动性的评估. 四川大学学报(医学版). 2015(02): 267-271+158 .

    Other cited types(12)

Catalog

    Article views (6321) PDF downloads (260) Cited by(39)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return